Aigen Investment Management LP Takes Position in Agilent Technologies, Inc. $A

Aigen Investment Management LP purchased a new stake in Agilent Technologies, Inc. (NYSE:A) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 4,840 shares of the medical research company’s stock, valued at approximately $659,000.

Several other hedge funds have also bought and sold shares of the business. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Agilent Technologies by 116.1% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 919,383 shares of the medical research company’s stock worth $125,100,000 after buying an additional 494,006 shares during the last quarter. Aptus Capital Advisors LLC boosted its holdings in shares of Agilent Technologies by 6.0% in the 4th quarter. Aptus Capital Advisors LLC now owns 3,510 shares of the medical research company’s stock worth $478,000 after buying an additional 198 shares during the last quarter. Arete Wealth Advisors LLC purchased a new position in shares of Agilent Technologies in the 4th quarter worth about $216,000. CreativeOne Wealth LLC purchased a new position in shares of Agilent Technologies in the 4th quarter worth about $219,000. Finally, Kestra Advisory Services LLC boosted its holdings in shares of Agilent Technologies by 7.9% in the 4th quarter. Kestra Advisory Services LLC now owns 10,707 shares of the medical research company’s stock worth $1,457,000 after buying an additional 781 shares during the last quarter.

Agilent Technologies Trading Down 0.1%

Shares of A opened at $129.76 on Monday. The business’s 50-day moving average price is $120.24 and its 200-day moving average price is $127.68. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.27. The stock has a market cap of $36.65 billion, a PE ratio of 26.06, a P/E/G ratio of 2.31 and a beta of 1.26. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.84 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the prior year, the business posted $1.31 earnings per share. The company’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities analysts forecast that Agilent Technologies, Inc. will post 6 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be given a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is 20.48%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Wells Fargo & Company cut their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. HSBC lowered their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Royal Bank Of Canada assumed coverage on Agilent Technologies in a research note on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price objective on the stock. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Finally, Wolfe Research restated a “hold” rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $160.93.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.